Longevity clinics help clients extend their health span by combining advanced diagnostics, biomarkers, and lifestyle interventions. While genetic testing and biological age tracking are powerful tools, many clients also want to know what’s happening in their body right now.
The miRoncol Real-time Multi-Cancer Early Risk Assessment provides that perspective: a blood-based, real-time molecular snapshot of cancer-associated signals that complements existing longevity and wellness programs.
Add molecular risk testing alongside biological age and metabolic health markers.
Track how molecular signals evolve with age, lifestyle, or interventions.
Provide clients with a more complete view of their health today, not just their genetic predisposition.
The miRoncol's test is an early risk assessment, not diagnostic. Results must always be reviewed with a physician and are designed to complement, not replace, conventional screening
By integrating miRoncol’s Real-time Multi-Cancer Early Risk Assessment, longevity clinics can expand their preventive offerings and give clients meaningful insight into cancer risk — today and over time.